NCT07174336 2026-04-17A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Eli Lilly and CompanyPhase 3 Recruiting920 enrolled
NCT05169567 2026-01-16postMONARCHEli Lilly and CompanyPhase 3 Active not recruiting368 enrolled 14 charts
NCT04975308 2025-07-11EMBER-3Eli Lilly and CompanyPhase 3 Active not recruiting874 enrolled 29 charts 2 FDA
NCT05288166 2025-06-27CYCLONE 3Eli Lilly and CompanyPhase 3 Active not recruiting925 enrolled 12 charts